Clinakos

Uncategorized

Clinakos, Integrated Patient Data, Medically Smart AI, Pharmaceuticals, Pharma, Commercial

Advantages of Clinakos’ Approach For Commercial

Advantages of Clinakos’ Approach For Commercial September 10, 2024 The McKinsey Global Institute (MGI) estimates that AI technologies could generate between $60 billion and $110 billion annually for the pharmaceutical and medical-product industries. At Clinakos Inc., we harness the power of Integrated Patient Data™ and Medically Smart AI™ to deliver real-time insights that drive smarter,

Advantages of Clinakos’ Approach For Commercial Read More »

Breaking Barriers in Rare Disease Research with Clinakos

Breaking Barriers in Rare Disease Research with Clinakos September 5, 2024 Previous Next According to the National Organization for Rare Disorders (NORD), over 7,000 rare diseases impact millions of patients, yet fewer than 500 have FDA-approved treatments. For patients living with rare diseases, the journey to a diagnosis is often long and difficult, with many

Breaking Barriers in Rare Disease Research with Clinakos Read More »

Advancing Lifesciences with FDA's New Real-World Evidence Guidelines

Exploring the New Frontiers in Real-World Evidence

Exploring the New Frontiers in Real-World Evidence August 21, 2024 https://clinakos.com/wp-content/uploads/2024/08/RWE-Post_Mp4.mp4 The FDA‘s recent guidance on using real-world evidence (RWE) in observational research has opened new pathways for innovation in healthcare research. As we embrace these changes, it’s crucial to consider how we can further enhance the utility of #RWE. Here are three pivotal areas

Exploring the New Frontiers in Real-World Evidence Read More »

Clinakos, Pharmaceuticals, Rare Diseases, NLP, AI, Medically Smart AI, Patient Data

Transforming Lifesciences with NLP

Transforming Patient Outcomes – Duplicate – [#1668] August 15, 2024 According to Gramener, a Gartner-recognized company, Natural Language Processing (NLP) is projected to add $4.3 billion in revenue to the healthcare market by 2026. Clinakos Inc.‘s Medically Smart AI™ leverages NLP and Machine Learning (ML) to ignite innovation and improve patient outcomes. Our AI-driven insights

Transforming Lifesciences with NLP Read More »

Patient360, Clinakos, Pharmaceutical, Medically Smart AI, Patient Data, AI, Healthcare

Transforming Healthcare with Patient360

Transforming Healthcare with Patient360 August 8, 2024 Clinakos’ Integrated Patient Data is linked and curated from thousands of data sources from EHRs, lab results, imaging reports, SDOH, and patient-reported outcomes. This integrated approach enables a holistic Patient360 view of the patients to understand the full scope of a patient’s medical history, leading to more informed

Transforming Healthcare with Patient360 Read More »

Scroll to Top

Connect with us